全文获取类型
收费全文 | 4137篇 |
免费 | 291篇 |
国内免费 | 15篇 |
专业分类
耳鼻咽喉 | 55篇 |
儿科学 | 82篇 |
妇产科学 | 91篇 |
基础医学 | 551篇 |
口腔科学 | 63篇 |
临床医学 | 460篇 |
内科学 | 776篇 |
皮肤病学 | 73篇 |
神经病学 | 231篇 |
特种医学 | 168篇 |
外科学 | 717篇 |
综合类 | 60篇 |
一般理论 | 2篇 |
预防医学 | 433篇 |
眼科学 | 92篇 |
药学 | 251篇 |
中国医学 | 3篇 |
肿瘤学 | 335篇 |
出版年
2023年 | 33篇 |
2022年 | 50篇 |
2021年 | 122篇 |
2020年 | 87篇 |
2019年 | 123篇 |
2018年 | 127篇 |
2017年 | 80篇 |
2016年 | 87篇 |
2015年 | 125篇 |
2014年 | 148篇 |
2013年 | 221篇 |
2012年 | 282篇 |
2011年 | 295篇 |
2010年 | 202篇 |
2009年 | 156篇 |
2008年 | 233篇 |
2007年 | 233篇 |
2006年 | 232篇 |
2005年 | 216篇 |
2004年 | 228篇 |
2003年 | 193篇 |
2002年 | 161篇 |
2001年 | 42篇 |
2000年 | 48篇 |
1999年 | 47篇 |
1998年 | 37篇 |
1997年 | 31篇 |
1996年 | 16篇 |
1995年 | 26篇 |
1994年 | 25篇 |
1993年 | 24篇 |
1992年 | 33篇 |
1991年 | 35篇 |
1990年 | 34篇 |
1989年 | 31篇 |
1988年 | 21篇 |
1987年 | 17篇 |
1986年 | 18篇 |
1985年 | 23篇 |
1984年 | 22篇 |
1983年 | 30篇 |
1982年 | 11篇 |
1980年 | 12篇 |
1979年 | 18篇 |
1978年 | 15篇 |
1973年 | 12篇 |
1969年 | 10篇 |
1930年 | 12篇 |
1927年 | 10篇 |
1926年 | 11篇 |
排序方式: 共有4443条查询结果,搜索用时 15 毫秒
81.
82.
Danny Markabawi Harvir Singh-Gambhir 《The American journal of emergency medicine》2018,36(7):1325.e1-1325.e2
Acute renal infarction is a relatively rare and scarcely reported condition. Contrast enhanced CT scan is essential for diagnosing this condition. The most common etiology of this condition is cardioembolic, however up to 59% of cases could be classified as idiopathic acute renal infarction.Here we present a case of a 41?year-old male who was admitted for acute onset right flank pain with fevers and rigors. A CT abdomen with contrast showed findings concerning for right pyelonephritis or renal infarction. Urinalysis was negative for infection. He did not respond to treatment with intravenous antibiotics and was thus diagnosed with acute renal infarction. Work-up for common etiologies was negative and the renal infarction was presumed to be idiopathic. He was discharged home on Enoxaparin.In conclusion, acute renal infarction is a rare condition which should be suspected in patients presenting with acute flank/abdominal pain in whom the more common etiologies have been ruled out. 相似文献
83.
84.
85.
86.
Blythe Adamson Wafaa El-Sadr Dobromir Dimitrov Theresa Gamble Geetha Beauchamp Josh J. Carlson Louis Garrison Deborah Donnell 《Value in health》2019,22(2):194-202
Objective
To evaluate the cost-effectiveness of financial incentives for human immunodeficiency virus (HIV) viral suppression compared to standard of care.Study Design
Mathematical model of 2-year intervention offering financial incentives ($70 quarterly) for viral suppression (<400 copies/ml3) based on the HPTN 065 clinical trial with HIV patients in the Bronx, NY and Washington, D.C.Methods
A disease progression model with HIV transmission risk equations was developed following guidelines from the Second Panel on Cost-Effectiveness in Health and Medicine. We used health care sector and societal perspectives, 3% discount rate, and lifetime horizon. Data sources included trial data (baseline N = 16,208 patients), CDC HIV Surveillance data, and published literature. Outcomes were costs (2017 USD), quality-adjusted life years (QALYs), HIV infections prevented, and incremental cost-effectiveness ratio (ICER).Results
Financial incentives for viral suppression were estimated to be cost-saving from a societal perspective and cost-effective ($49,877/QALY) from a health care sector perspective. Compared to the standard of care, financial incentives gain 0.06 QALYs and lower discounted lifetime costs by $4210 per patient. The model estimates that incentivized patients transmit 9% fewer infections than the standard-of-care patients. In the sensitivity analysis, ICER 95% credible intervals ranged from cost-saving to $501,610/QALY with 72% of simulations being cost-effective using a $150,000/QALY threshold. Modeling results are limited by uncertainty in efficacy from the clinical trial.Conclusions
Financial incentives, as used in HTPN 065, are estimated to improve quality and length of life, reduce HIV transmissions, and save money from a societal perspective. Financial incentives offer a promising option for enhancing the benefits of medication in the United States. 相似文献87.
Jason M. Mehal Robert C. Holman Danny A. Brass Jesse D. Blanton Brett W. Petersen 《The American journal of tropical medicine and hygiene》2014,90(2):263-264
The purpose of the study was to evaluate changes in the knowledge of bat rabies and human exposure among United States cavers during the last decade. A survey was distributed among cavers who attended the National Speleological Society convention in 2000 and those who attended in 2010. In 2000 and 2010, 392 and 108 cavers, respectively, responded to the questionnaire. Eighty-five per cent of respondents in 2000 indicated a bat bite as a risk for rabies compared with all respondents in 2010 (P < 0.0001 controlling for age). The proportion of respondents indicating that they were advised to receive rabies pre-exposure prophylaxis (PreEP) because of caving increased (17% and 29%; P = 0.03 controlling for age). Among these, PreEP was received by 56% and 45%. Although recognition of the risk of rabies exposure from bats is important, the proportion of cavers acting on current recommendations regarding PreEP does not appear to have improved in the past decade. 相似文献
88.
89.
90.